REITWAVE.COM Institutional Equity Tear Sheet Generator
Download Vector PDF Export Model (CSV)
REITWAVE.COM | INSTITUTIONAL REAL ESTATE RESEARCH
AS OF: OCTOBER 24, 2026  |  10Y TREASURY: 4.99%  |  SIC 6798

Community Healthcare Trust ($CHCT)

Sector: Healthcare  •  Exchange / CIK: NYSE / 0001631569  •  Properties: 185 Assets
Trading at a 12.3% discount to NAV
Safety Score: 45/100 (Elevated Risk)  |  Credit: Not Rated

Live Share Price

$13.00
52W Range: $12.58 - $19.16

Valuation Multiples

8.8x P/AFFO
P/FFO: 8.0x  |  FFO/sh: $1.62

Net Asset Value (NAV)

$15.10
Prem/Disc: -12.3%  |  Cap: 6.84%

Dividend Cash Flow

14.31% Yield
$1.86/yr (Quarterly)  |  Payout: 125.7%
Balance Sheet & Debt Maturity Sentry
Net Debt to EBITDAre stands at 6.8x. Portfolio leased occupancy is 89.8% with a weighted average lease term (WALT) of 6.4 years. Senior credit rating of Not Rated provides institutional capital markets access for debt refinancing.
Recent Dividend Payment History (Last 6 Declarations)
Ex-Dividend Date Record / Pay Date Cash Distribution Status / Corporate Action
2026-09-30 2026-10-15 $0.4650 Regular Distribution
Representative Commercial Asset Concentrations (From SEC Form 10-K Item 2)
Commercial Asset / Property Name Location Rentable Sq Ft Occupancy Implied Asset Valuation
Community Healthcare Trust Flagship Commercial Portfolio United States Nationwide 23,125,000 sq ft (implied) 89.8% $2,265,000,000
Quantitative Risk & Benchmark Performance (QuantStats • VNQ)
Empirical 252-day trading window compared to Vanguard Real Estate ETF (VNQ) benchmark
METHODOLOGY: QUANTSTATS / CAPM
Beta vs VNQ
0.9
Index Tracking (Market Neutral)
Annualized Alpha (α)
-1.11%
Trailing VNQ
Sharpe Ratio (vs VNQ)
-0.04 vs 0.04
-0.08 Spread
Max Drawdown (1-Yr)
-32.0% vs -11.4%
-20.6% vs VNQ
CHCT vs VNQ QuantStats Performance & Underwater Drawdown
Quantitative Risk & Return Metric CHCT VNQ (Benchmark) Institutional Delta / Spread
Beta (β) vs VNQ
Covariance sensitivity to US REIT market
0.9 1.00 -0.10 (Index Tracking (Market Neutral))
Annualized Alpha (α)
Excess CAPM risk-adjusted performance
-1.11% 0.00% (Baseline) Trailing VNQ
Sharpe Ratio (Rf = 4.5%)
Annualized excess return per unit of volatility
-0.04 0.04 -0.08
Sortino Ratio
Downside semi-variance risk-adjusted return
-0.03 0.03 -0.06
Annualized Volatility (σ)
Standard deviation of daily price returns × √252
27.3% 13.9% +13.4% (Higher Volatility)
Maximum Drawdown (1-Year)
Peak-to-trough capital decline over trailing 12M
-32.0% -11.4% -20.6% vs VNQ
1-Year Trailing Return (CAGR)
Compounded annual growth rate
-0.4% 4.1% -4.5% Spread
R-Squared (R²) & Correlation
Statistical correlation coefficient against VNQ
R² 0.21 Corr: 0.46 21% variance explained by VNQ
Trading Session Win Rate
Percentage of positive daily closing sessions
54.4% 51.6% +2.8% vs Benchmark
QuantStats Analytical Synthesis: CHCT displays a Beta of 0.90 relative to VNQ with 0.21 R² correlation. Annualized volatility is 27.3% (13.3% higher than VNQ at 13.9%). Trailing 12-month Alpha stands at -1.11% (Trailing VNQ) with a Sharpe ratio of -0.04 against 0.04 for VNQ, and a maximum drawdown of -32.0%.
SEC CIK: 0001631569  |  Principal Executive Officer: David H. Emery  |  Total PEO Compensation: $3,200,000 (32:1)
Official SEC Accession: 0001631282-26-000011
CONFIDENTIAL INSTITUTIONAL TEAR SHEET • REITWAVE.COM (v1.0.0) • Data Sources: SEC EDGAR Form 10-K / DEF 14A, PR Newswire, Bloomberg/CBRE Comps. For institutional and accredited investor due diligence. Not a solicitation or investment recommendation.